What serious lung problems have been reported with Herceptin (trastuzumab)?

Herceptin (trastuzumab) has been associated with severe, occasionally fatal pulmonary events, including interstitial lung disease, lung infiltrates, acute respiratory distress syndrome, pneumonia, pneumonitis, pleural effusion, respiratory distress, acute pulmonary oedema and respiratory insufficiency.